| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |